Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism A1R antagonists(Adenosine A1 receptor antagonists), A2aR antagonists(Adenosine A2a receptor antagonists), COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (14 Jan 1998), |
Regulation- |
Molecular FormulaC8H10N4O2 |
InChIKeyRYYVLZVUVIJVGH-UHFFFAOYSA-N |
CAS Registry58-08-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Migraine Disorders | US | 14 Jan 1998 |
Phase 4 | 93 | (Aspirin, Acetaminophen, Caffeine Pills) | wecbfodnrx(abrgplcxsc) = gonuudsequ xcnljaugjz (lsnqtppudy, phxsyxxvym - yfqypzszzn) View more | - | 18 Mar 2020 | ||
(Prochlorperazine 10mg) | wecbfodnrx(abrgplcxsc) = jrhsmcfrqz xcnljaugjz (lsnqtppudy, cetvknjnsb - uwoybpayvs) View more |